We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Genaissance Enters into HAP™ Technology License Agreement with Sankyo

The goal of the collaboration is to discover genetic markers related to drug response.
News

Detecting Genetic Risk Factors For Type 1 Diabetes

Researchers are using TaqMan® Gene Expression Assays to identify the genetic risk factors for type 1diabetes.
News

Angiotech Announces Drug Discovery And Development Agreement with CombinatoRx

The agreement provides Angiotech with immediate access to CombinatoRx's combination pharmaceutical compounds.
News

Training Grants Awarded for Nanobiotechnology

National Cancer Institute and National Science Foundation Launch Collaboration.
News

Official Inaugurated of Nanofab

Nanofab is said to be in the forefront of European nanotechnology laboratories designed and dedicated to transfer nanotechnologies in the materials sector to industrial production.
News

UBI to Market RBC's HIT Competent Cells in Canada

UBI uses Post Grads and Post Docs working in Canadian academic labs to provide marketing and support to the labs that use UBI products.
News

NIH Renews Its Pharmacogenetics Research Network

The NIH anticipates spending $150 million over five years to renew its Pharmacogenetics Research Network.
News

Merck Signs Research and Drug Development Agreement with FoxHollow

The collaboration will help in identifying biomarkers of atherosclerotic disease progression for use in the development of cardiovascular compounds in Merck's pipeline.
News

Effectiveness of Drug Screening System Utilizing Active Learning

NEC has announced that it has verified the effectiveness of the drug screening system, ChemMiner™.
News

Celliance Acquires Gene Expression Technology

The UCOE technology will augment Celliance’s cell line development and protein expansion capabilities.
Advertisement